Infantile undifferentiated sarcomas: a diagnostic and therapeutic challenge – two case reports and literature review
DOI:
https://doi.org/10.2340/1651-226X.2025.42162Keywords:
undifferentiated sarcoma, infancy, progression, aggressive chemotherapy, chemotherapy toxicityAbstract
Background: Soft tissue undifferentiated sarcomas (STUS) are an ultra-rare and heterogenous group of mesenchymal neoplasms often lacking known genetic abnormalities with a marked vulnerability towards intensive therapy such as invasive surgery and high dose chemotherapy. Despite aggressive treatment, they are usually associated with dismal outcomes.
Case presentation: Here we describe two cases of STUS in 3-week-old and 3-month-old infants localized on the neck and the trunk area.
Discussion: In both cases, the malignancy had a fatal outcome due to the toxicity of intensive therapy in one case and the progression of the disease in the other. The purpose of this report is to discuss the clinical challenges of managing infancy-related STUS such as limited treatment options and poor prognosis.
Downloads
References
Palumbo JS, Zwerdling T. Soft tissue sarcomas of infancy. Semin Perinatol. 1999;23(4):299–309.
https://doi.org/10.1016/S0146-0005(99)80038-X DOI: https://doi.org/10.1016/S0146-0005(99)80038-X
Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2020;113(2):
70–84.
https://doi.org/10.32074/1591-951X-213 DOI: https://doi.org/10.32074/1591-951X-213
Mezri S, Zitouni C, Abid I, Gargouri F, Laabidi B, Akari K. Undifferentiated small round cell sarcoma of the hypopharynx in a 7-month-old patient. Ear Nose Throat J. 2023. Nov 24:1455613231215196 https://doi.org/10.1177/01455613231215196 DOI: https://doi.org/10.1177/01455613231215196
Antonescu CR, Kao YC, Xu B, Fujisawa Y, Chung C, Fletcher CDM, et al. Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study. Mod Pathol. 2020;33(9):1669–77.
https://doi.org/10.1038/s41379-020-0557-5 DOI: https://doi.org/10.1038/s41379-020-0557-5
Ogun GO, Ezenkwa US, Babatunde TO, Obiagwu AE, Nweke MC, Adegoke OO, et al. Paediatric soft tissue sarcomas in a resource constraint setting: grade and stage at presentation and at oncologic intervention are usually of poor prognostic characteristics. Int J Clin Pract. 2021;75(4):e13951.
https://doi.org/10.1111/ijcp.13951 DOI: https://doi.org/10.1111/ijcp.13951
Pierron G, Tirode F, Lucchesi C, Reynaud S, Ballet S, Cohen-Gogo S, et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet. 2012;44(4):461–6.
https://doi.org/10.1038/ng.1107 DOI: https://doi.org/10.1038/ng.1107
Yoshida A, Arai Y, Hama N, Chikuta H, Bando Y, Nakano S, et al. Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults. Histopathology. 2020;76(4):509–20.
https://doi.org/10.1111/his.14023 DOI: https://doi.org/10.1111/his.14023
Malik F, Zreik RT, Hedges DJ, Nakitandwe J, Lee S, Ward RA, et al. Primary bone sarcoma with BCOR internal tandem duplication. Virchows Arch. 2020;476(6):915–20.
https://doi.org/10.1007/s00428-019-02729-z DOI: https://doi.org/10.1007/s00428-019-02729-z
Sparber-Sauer M, Corradini N, Affinita MC, Milano GM, Pierron G, Carton M, et al. Clinical characteristics and outcomes for children, adolescents and young adults with ‘CIC‐fused’ or ‘BCOR‐rearranged’ soft tissue sarcomas: a multi‐institutional European retrospective analysis. Cancer Med. 2023;12(13):14346–59.
https://doi.org/10.1002/cam4.6113 DOI: https://doi.org/10.1002/cam4.6113
Kao YC, Sung YS, Zhang L, Huang SC, Argani P, Chung CT, et al. Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol. 2016;40(8):1009–20.
https://doi.org/10.1097/PAS.0000000000000629 DOI: https://doi.org/10.1097/PAS.0000000000000629
Roy A, Kumar V, Zorman B, Fang E, Haines KM, Doddapaneni H, et al. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. Nat Commun. 2015;6(1):8891.
https://doi.org/10.1038/ncomms9891 DOI: https://doi.org/10.1038/ncomms9891
Wardelmann E, Hartmann W. Neues in der aktuellen WHO-Klassifikation (2020) für Weichgewebssarkome. Pathologe. 2021;42(3):281–93.
https://doi.org/10.1007/s00292-021-00935-8 DOI: https://doi.org/10.1007/s00292-021-00935-8
Yoshida Y, Nobusawa S, Nakata S, Nakada M, Arakawa Y, Mineharu Y, et al. CNS high‐grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue. Brain Pathol. 2018;28(5):710–20.
https://doi.org/10.1111/bpa.12585 DOI: https://doi.org/10.1111/bpa.12585
Santiago T, Clay MR, Allen SJ, Orr BA. Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. Mod Pathol. 2017;30(6):884–91.
https://doi.org/10.1038/modpathol.2017.12 DOI: https://doi.org/10.1038/modpathol.2017.12
Mariño-Enriquez A, Lauria A, Przybyl J, Ng TL, Kowalewska M, Debiec-Rychter M, et al. BCOR internal tandem duplication in high-grade uterine sarcomas. Am J Surg Pathol. 2018;42(3):335–41.
https://doi.org/10.1097/PAS.0000000000000993 DOI: https://doi.org/10.1097/PAS.0000000000000993
Penel N, Mallet Y, Robin YM, Fournier C, Grosjean J, Ceugnart L, et al. Prognostic factors for adult sarcomas of head and neck. Int J Oral Maxillofac Surg. 2008;37(5):428–32.
https://doi.org/10.1016/j.ijom.2008.01.019 DOI: https://doi.org/10.1016/j.ijom.2008.01.019
Bahador A, Forooghi M, Shahriarirad R, Geramizadeh B, Ataollahi M, Kamran H. A large undifferentiated sarcoma of the liver in a 13-year-old girl treated with anatomical resection: a case report and review of the literature. BMC Gastroenterol. 2022;22(1):2.
https://doi.org/10.1186/s12876-021-02076-x DOI: https://doi.org/10.1186/s12876-021-02076-x
Renzi S, Cullinan N, Cohen-Gogo S, Langenberg-Ververgaert K, Michaeli O, Alkendi J, et al. Non‐rhabdomyosarcoma soft tissue sarcomas diagnosed in patients at a young age. An overview of clinical, pathological, and molecular findings. Pediatr Blood Cancer. 2021;68(8):e29022.
https://doi.org/10.1002/pbc.29022 DOI: https://doi.org/10.1002/pbc.29022
Souzaki R, Kinoshita Y, Matsuura T, Tajiri T, Taguchi T, Ieiri S, et al. Successful resection of an undifferentiated sarcoma in a child using a real-time surgical navigation system in an open magnetic resonance imaging operation room. J Pediatr Surg. 2011;46(3):608–11.
https://doi.org/10.1016/j.jpedsurg.2010.11.043 DOI: https://doi.org/10.1016/j.jpedsurg.2010.11.043
Kawaguchi K, Igarashi K, Kiyuna T, Miyake K, Miyake M, Murakami T, et al. Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients. Cell Cycle. 2018;17(5):627–33.
https://doi.org/10.1080/15384101.2017.1421876 DOI: https://doi.org/10.1080/15384101.2017.1421876
Kyriazoglou A, Bagos P. Meta-analysis of BCOR rearranged sarcomas: challenging the therapeutic approach. Acta Oncol. 2021;60(6):
721–6.
https://doi.org/10.1080/0284186X.2021.1890818 DOI: https://doi.org/10.1080/0284186X.2021.1890818
Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, et al. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children’s Cancer Group (CCG) experience. Pediatr Blood Cancer. 2005;44(4):338–47.
https://doi.org/10.1002/pbc.20227 DOI: https://doi.org/10.1002/pbc.20227
Oberlin O, Rey A, Sanchez de Toledo J, Martelli H, Jenney ME, Scopinaro M, et al. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 Study. J Clin Oncol. 2012;30(20):2457–65.
https://doi.org/10.1200/JCO.2011.40.3287 DOI: https://doi.org/10.1200/JCO.2011.40.3287
Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants. Clin Pharmacokinet. 2002;41:1077–94.
https://doi.org/10.2165/00003088-200241130-00005 DOI: https://doi.org/10.2165/00003088-200241130-00005
Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology – drug disposition, action and therapy in infants and children. N Engl J Med. 2006;349:1157–67.
https://doi.org/10.1056/NEJMra035092 DOI: https://doi.org/10.1056/NEJMra035092
Anderson BJ. My child is unique; the pharmacokinetics are universal. Paediatr Anaesth. 2012;22(6):530–8.
https://doi.org/10.1111/j.1460-9592.2011.03788.x DOI: https://doi.org/10.1111/j.1460-9592.2011.03788.x
Bartelink IH, Rademaker CM, Schobben AF, van den Anker JN. Guidelines on pediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet. 2006;45:1077–97.
https://doi.org/10.2165/00003088-200645110-00003 DOI: https://doi.org/10.2165/00003088-200645110-00003
Sajith M, Pawar A, Bafna V, Bartakke S. High-dose methotrexate-induced fulminant hepatic failure and pancytopenia in an acute lymphoblastic leukaemia paediatric patient. Eur J Hosp Pharm. 2020;27(3):178–80.
https://doi.org/10.1136/ejhpharm-2019-001944 DOI: https://doi.org/10.1136/ejhpharm-2019-001944
El Masri AER, Tobler C, Willemijn B, Von Bueren AO, Ansari M, Samer CF. Case report: hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023? Front Pharmacol. 2023;14:1130548.
https://doi.org/10.3389/fphar.2023.1130548 DOI: https://doi.org/10.3389/fphar.2023.1130548
Aiba H, Yamada S, Mizutani J, Yamamoto N, Okamoto H, Hayashi K, et al. Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series. PLoS One. 2018;13(4):e0195289.
https://doi.org/10.1371/journal.pone.0195289 DOI: https://doi.org/10.1371/journal.pone.0195289
Sadikovic B, Graham C, Ho M, Zielenska M, Somers GR. Immunohistochemical expression and cluster analysis of mesenchymal and neural stem cell–associated proteins in pediatric soft tissue sarcomas. Pediatr Dev Pathol. 2011;14(4):259–72.
https://doi.org/10.2350/10-08-0890-OA.1 DOI: https://doi.org/10.2350/10-08-0890-OA.1
Machado I, Yoshida A, Morales MGN, Abrahão-Machado LF, Navarro S, Cruz J, et al. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, ‘undifferentiated small round cell tumors’. A clinicopathologic, immunophenotypic and molecular analysis. Ann Diagn Pathol. 2018;34:1–12.
https://doi.org/10.1016/j.anndiagpath.2017.11.011 DOI: https://doi.org/10.1016/j.anndiagpath.2017.11.011
Palmerini E, Gambarotti M, Italiano A, Nathenson MJ, Ratan R, Dileo P, et al. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl). Eur J Cancer. 2023;183:11–23.
https://doi.org/10.1016/j.ejca.2023.01.003 DOI: https://doi.org/10.1016/j.ejca.2023.01.003
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Aleksandra Stanio, Jakub Czarny, Sandra Rutkowska, Katarzyna Adamczewska-Wawrzynowicz, Łukasz Młynarczyk, Agnieszka Stróżyk, Katarzyna Jończyk-Potoczna, Alicja Bartkowska-Śniatkowska, Jacek Wachowiak, Katarzyna Derwich, Olga Zając-Spychała
This work is licensed under a Creative Commons Attribution 4.0 International License.
